Notice2024-16813
National Cancer Institute; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
July 31, 2024
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 147 (Wednesday, July 31, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 147 (Wednesday, July 31, 2024)]
[Notices]
[Pages 61489-61490]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-16813]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute, Special Emphasis
Panel; SEP-1: NCI Clinical and Translational Cancer Research.
Date: September 19, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute, Shady Grove, 9609 Medical
Center Drive, Room 7W108, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Clifford W. Schweinfest, Ph.D., Scientific
Review Officer, Special Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W108, Rockville, Maryland 20850, 240-276-6343,
<a href="/cdn-cgi/l/email-protection#e794848f90828e89818294938490a78a868e8bc9898e8fc9808891"><span class="__cf_email__" data-cfemail="99eafaf1eefcf0f7fffceaedfaeed9f4f8f0f5b7f7f0f1b7fef6ef">[email protected]</span></a>.
Name of Committee: National Cancer Institute, Special Emphasis
Panel; SEP-4: NCI Clinical and Translational Cancer Research.
Date: September 24, 2024.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W264, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Ombretta Salvucci, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W264, Rockville, Maryland 20850, 240-276-7286,
<a href="/cdn-cgi/l/email-protection#f281939e848791919db29f939b9edc9c9b9adc959d84"><span class="__cf_email__" data-cfemail="5f2c3e33292a3c3c301f323e36337131363771383029">[email protected]</span></a>.
Name of Committee: National Cancer Institute, Special Emphasis
Panel; Projects in Physical Sciences and Oncology (U01) Review.
Date: September 25, 2024.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W640, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Saejeong J. Kim, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W640, Rockville, Maryland 20850, 240-276-7684,
<a href="/cdn-cgi/l/email-protection#addeccc8c7c8c2c3ca83c6c4c0edc3c4c583cac2db"><span class="__cf_email__" data-cfemail="255644404f404a4b420b4e4c48654b4c4d0b424a53">[email protected]</span></a>.
Name of Committee: National Cancer Institute, Special Emphasis
Panel; Clinical Trials Planning Program.
Date: October 4, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room
[[Page 61490]]
7W106, Rockville, Maryland 20850 (Virtual Meeting).
Contact Person: Eduardo Emilio Chufan, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W106, Rockville, Maryland 20850, 240-276-7975,
<a href="/cdn-cgi/l/email-protection#f99a918c9f98979c9cb994989095d7979091d79e968f"><span class="__cf_email__" data-cfemail="8ae9e2ffecebe4efefcae7ebe3e6a4e4e3e2a4ede5fc">[email protected]</span></a>.
Name of Committee: National Cancer Institute, Special Emphasis
Panel; SEP-9: NCI Clinical and Translational Cancer Research.
Date: October 9, 2024.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W640, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Saejeong J. Kim, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W640, Rockville, Maryland 20850, 240-276-7684,
<a href="/cdn-cgi/l/email-protection#89fae8ece3ece6e7eea7e2e0e4c9e7e0e1a7eee6ff"><span class="__cf_email__" data-cfemail="dba8babeb1beb4b5bcf5b0b2b69bb5b2b3f5bcb4ad">[email protected]</span></a>.
Name of Committee: National Cancer Institute, Special Emphasis
Panel; SEP-12: NCI Clinical and Translational Cancer Research.
Date: October 16, 2024.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute, Shady Grove, 9609 Medical
Center Drive, Room 7W246, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Jun Fang, Ph.D., Scientific Review Officer,
Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W246, Rockville, Maryland 20850, 240-276-5460,
<a href="/cdn-cgi/l/email-protection#cca6aaada2ab8ca1ada5a0e2a2a5a4e2aba3ba"><span class="__cf_email__" data-cfemail="462c20272821062b272f2a68282f2e68212930">[email protected]</span></a>.
Name of Committee: National Cancer Institute, Special Emphasis
Panel; SEP-8: NCI Clinical and Translational Cancer Research.
Date: October 29-30, 2024.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W110, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Priya Srinivasan, Ph.D., Scientific Review
Officer, Resource and Training Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W110, Rockville, Maryland 20850, 240-276-5619,
<a href="/cdn-cgi/l/email-protection#49393b203028673a3b2027203f283a282709272021672e263f"><span class="__cf_email__" data-cfemail="4737352e3e266934352e292e312634262907292e2f69202831">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Date: July 19, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2024-16813 Filed 7-30-24; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on July 31, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.